G vs. AUR, EPAM, CLS, TENB, NOVT, LFUS, ZI, ALGM, DV, and FYBR
Should you be buying Genpact stock or one of its competitors? The main competitors of Genpact include Aurora Innovation (AUR), EPAM Systems (EPAM), Celestica (CLS), Tenable (TENB), Novanta (NOVT), Littelfuse (LFUS), ZoomInfo Technologies (ZI), Allegro MicroSystems (ALGM), DoubleVerify (DV), and Frontier Communications Parent (FYBR).
Genpact (NYSE:G) and Aurora Innovation (NASDAQ:AUR) are both mid-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, community ranking, dividends, profitability and media sentiment.
Genpact has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Aurora Innovation has a beta of 2.91, indicating that its share price is 191% more volatile than the S&P 500.
Genpact received 482 more outperform votes than Aurora Innovation when rated by MarketBeat users. Likewise, 68.44% of users gave Genpact an outperform vote while only 33.33% of users gave Aurora Innovation an outperform vote.
96.0% of Genpact shares are held by institutional investors. Comparatively, 44.7% of Aurora Innovation shares are held by institutional investors. 2.8% of Genpact shares are held by insiders. Comparatively, 13.8% of Aurora Innovation shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Genpact has higher revenue and earnings than Aurora Innovation. Aurora Innovation is trading at a lower price-to-earnings ratio than Genpact, indicating that it is currently the more affordable of the two stocks.
Genpact has a net margin of 14.10% compared to Aurora Innovation's net margin of 0.00%. Genpact's return on equity of 23.19% beat Aurora Innovation's return on equity.
Genpact presently has a consensus target price of $39.78, suggesting a potential upside of 28.73%. Aurora Innovation has a consensus target price of $3.75, suggesting a potential upside of 24.17%. Given Genpact's higher probable upside, analysts clearly believe Genpact is more favorable than Aurora Innovation.
In the previous week, Genpact had 12 more articles in the media than Aurora Innovation. MarketBeat recorded 15 mentions for Genpact and 3 mentions for Aurora Innovation. Genpact's average media sentiment score of 0.27 beat Aurora Innovation's score of 0.25 indicating that Genpact is being referred to more favorably in the media.
Summary
Genpact beats Aurora Innovation on 13 of the 16 factors compared between the two stocks.
Get Genpact News Delivered to You Automatically
Sign up to receive the latest news and ratings for G and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding G and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
